Vactosertib in Combination with Pembrolizumab in Metastatic Colorectal or Gastric Cancer

NCT03724851 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer
Gastric Cancer
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: TEW-7197

Sponsor

MedPacto, Inc.

Collaborators

[object Object]